Cite
Gallagher JC, Satlin MJ, Elabor A, et al. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant . Open Forum Infect Dis. 2018;5(11):ofy280doi: 10.1093/ofid/ofy280.
Gallagher, J. C., Satlin, M. J., Elabor, A., Saraiya, N., McCreary, E. K., Molnar, E., El-Beyrouty, C., Jones, B. M., Dixit, D., Heil, E. L., Claeys, K. C., Hiles, J., Vyas, N. M., Bland, C. M., Suh, J., Biason, K., McCoy, D., King, M. A., Richards, L., Harrington, N., Guo, Y., Chaudhry, S., Lu, X., & Yu, D. (2018). Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant . Open forum infectious diseases, 5(11), ofy280. https://doi.org/10.1093/ofid/ofy280
Gallagher, Jason C, et al. "Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant ." Open forum infectious diseases vol. 5,11 (2018): ofy280. doi: https://doi.org/10.1093/ofid/ofy280
Gallagher JC, Satlin MJ, Elabor A, Saraiya N, McCreary EK, Molnar E, El-Beyrouty C, Jones BM, Dixit D, Heil EL, Claeys KC, Hiles J, Vyas NM, Bland CM, Suh J, Biason K, McCoy D, King MA, Richards L, Harrington N, Guo Y, Chaudhry S, Lu X, Yu D. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant . Open Forum Infect Dis. 2018 Oct 31;5(11):ofy280. doi: 10.1093/ofid/ofy280. eCollection 2018 Nov. PMID: 30488041; PMCID: PMC6247659.
Copy
Download .nbib